Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Kraus

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 24, 2010
Spiralometry: computerized assessment of tremor amplitude on the basis of spiral drawingPeter H Kraus, Arndt Hoffmann
Psychiatrische Praxis|October 13, 2005
[Amisulpride in Huntington's disease]Carsten Saft, Jürgen Andrich, Peter H Kraus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameterPeter H Kraus, Peter Klotz, Arndt Hoffmann, et al.
BMC Neurology|March 2, 2006
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case seriesCarsten Saft, Thorsten Lauter, Peter H Kraus, et al.
BMC Medical Genetics|October 6, 2005
Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)Larissa Arning, Peter H Kraus, Carsten Saft, et al.
Clinical Neuropharmacology|November 17, 2010
Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case reportAlexandra Schroeder, Ralf A Linker, Carsten Lukas, et al.
CNS Drugs|October 10, 2003
Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's diseaseHeinz Reichmann, Michael H Brecht, Jürgen Köster, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 9, 2005
Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexoleMatthias R Lemke, H Michael Brecht, Juergen Koester, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2008
Huntington's disease as caused by 34 CAG repeatsJürgen Andrich, Larissa Arning, Stefan Wieczorek, et al.
Human Genetics|June 15, 2007
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific mannerLarissa Arning, Carsten Saft, Stefan Wieczorek, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Movement Disorders : Official Journal of the Movement Disorder Society|June 24, 2010
Spiralometry: computerized assessment of tremor amplitude on the basis of spiral drawingPeter H Kraus, Arndt Hoffmann
Psychiatrische Praxis|October 13, 2005
[Amisulpride in Huntington's disease]Carsten Saft, Jürgen Andrich, Peter H Kraus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2004
Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameterPeter H Kraus, Peter Klotz, Arndt Hoffmann, et al.
BMC Neurology|March 2, 2006
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case seriesCarsten Saft, Thorsten Lauter, Peter H Kraus, et al.
BMC Medical Genetics|October 6, 2005
Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)Larissa Arning, Peter H Kraus, Carsten Saft, et al.
Clinical Neuropharmacology|November 17, 2010
Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case reportAlexandra Schroeder, Ralf A Linker, Carsten Lukas, et al.
CNS Drugs|October 10, 2003
Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's diseaseHeinz Reichmann, Michael H Brecht, Jürgen Köster, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 9, 2005
Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexoleMatthias R Lemke, H Michael Brecht, Juergen Koester, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2008
Huntington's disease as caused by 34 CAG repeatsJürgen Andrich, Larissa Arning, Stefan Wieczorek, et al.
Human Genetics|June 15, 2007
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific mannerLarissa Arning, Carsten Saft, Stefan Wieczorek, et al.
Pageof 2